IMMUNOLOGY_BOARD Telegram 1387
Forwarded from TREND IMMUNOLOGY (Pooya Farhangnia)
🔴پروفسور Carl June از دانشگاه پنسیلوانیا و پروفسور Michel Sadelain از Memorial Sloan Kettering Cancer Center برنده جایزه معتبر Breakthrough Prize in Life Sciences به دلیل تحقیقات پیشگامانه بر روی CAR T Cell Therapy شدند. به احتمال بسیار زیاد در سالیان آینده شاهد اعطای نوبل پزشکی به این دانشمندان خواهیم بود.

@Trend_Immunology
@Immunology_Board
@Sabaflow
@Usern_Net



tgoop.com/immunology_board/1387
Create:
Last Update:

🔴پروفسور Carl June از دانشگاه پنسیلوانیا و پروفسور Michel Sadelain از Memorial Sloan Kettering Cancer Center برنده جایزه معتبر Breakthrough Prize in Life Sciences به دلیل تحقیقات پیشگامانه بر روی CAR T Cell Therapy شدند. به احتمال بسیار زیاد در سالیان آینده شاهد اعطای نوبل پزشکی به این دانشمندان خواهیم بود.

@Trend_Immunology
@Immunology_Board
@Sabaflow
@Usern_Net

BY Advanced Lectures in Clinical Immunology & Cellular Therapeutics




Share with your friend now:
tgoop.com/immunology_board/1387

View MORE
Open in Telegram


Telegram News

Date: |

In 2018, Telegram’s audience reached 200 million people, with 500,000 new users joining the messenger every day. It was launched for iOS on 14 August 2013 and Android on 20 October 2013. 3How to create a Telegram channel? Telegram channels enable users to broadcast messages to multiple users simultaneously. Like on social media, users need to subscribe to your channel to get access to your content published by one or more administrators. Telegram message that reads: "Bear Market Screaming Therapy Group. You are only allowed to send screaming voice notes. Everything else = BAN. Text pics, videos, stickers, gif = BAN. Anything other than screaming = BAN. You think you are smart = BAN. Select: Settings – Manage Channel – Administrators – Add administrator. From your list of subscribers, select the correct user. A new window will appear on the screen. Check the rights you’re willing to give to your administrator.
from us


Telegram Advanced Lectures in Clinical Immunology & Cellular Therapeutics
FROM American